Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (278)
- COVID-19 (163)
- Safety monitoring and information (101)
- Legislation (95)
- Compliance and enforcement (70)
- Manufacturing (55)
- Vaping hub (55)
- Labelling and packaging (37)
- Import and export (28)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Weight loss products (15)
- Shortages and supply disruptions (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1266 result(s) found, displaying 426 to 450
-
Media releasesThe TGA has confirmed the performance of COVID-19 rapid antigen tests available on the Australian market with COVID-19 variants.
-
News articlesNew guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.
-
Regulatory decision noticesThis instrument is made under subsection 26BD(3) of the Therapeutic Goods Act 1989.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesThe TGA has issued infringement notices to Mode Medical Pty Ltd for the alleged unlawful advertising to Australian consumers on a company website and social media.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThis is the first vaccine provisionally approved by the TGA that is designed to specifically target the Omicron variants BA.4/BA.5 and follows provisional approval of the Pfizer BA.1 Omicron/original bivalent vaccine.
-
Media releasesThe TGA has commenced evaluation of an application from Moderna Australia Pty Ltd to transition its COVID-19 vaccine, SPIKEVAX, to full registration for the immunisation of individuals 6 years and over, and as a booster dose for individuals aged 12 years and older.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
News articlesCurrent antibiotics shortages in Australia include amoxicillin, amoxicillin/clavulanic acid, cefalexin, metronidazole and trimethoprim.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesThe Prescribing Medicines in Pregnancy database has now been updated.
-
News articlesThe Generic Medicines Work-Sharing Initiative has updated its Operational Procedures document and Expression Of Interest form.
-
Media releasesTravellers will be able to bring up to 3-months supply of their medicine.
-
Therapeutic Goods (Biologicals-Application Form for Priority Applicant Determinations) Approval 2022
Regulatory decision noticesApproval of the Therapeutic Goods (Biologicals—Application Form for Priority Applicant Determinations) -
News articlesBefore you take a weight loss supplement or medicine, there are things to consider.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
BlogMake small changes to how you think about paracetamol.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
News articlesA warning to social media influencers and advertisers not to advertise this prescription medicine.
-
Media releasesThe TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products in Australia.
-
Regulatory decision noticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.
-
Media releasesThe TGA has issued an infringement notice of $2,664 to a NSW-based medical practitioner for alleged unlawful advertising of nicotine vaping products in a social media post.